TNFRSF6B and glioblastoma: DDX6 is involved in radio- and chemoresistance in glioblastoma (Cho et al., 2016), and TNFRSF6B suppresses CD95 ligand-induced apoptosis and chemotaxis in malignant glioma (Roth et al., 2001).